Arthritis Foundation Joins Get Moving America Campaign for Osteoarthritis
WILMINGTON, Del., Oct. 28, 2013
WILMINGTON, Del., Oct. 28, 2013 /PRNewswire/ -- AstraZeneca today announced
that the Arthritis Foundation has joined the Get Moving America campaign, a
national initiative that encourages men and women to do daily simple movements
to help reduce chronic stiffness and pain associated with osteoarthritis (OA).
The Get Moving America campaign, sponsored by AstraZeneca, was launched last
month to establish a social media community that reaches, inspires, and
connects adults with OA.
"The Arthritis Foundation has joined forces with AstraZeneca to raise funds to
fight and cure arthritis," said Arthritis Foundation President and CEO Ann M.
Palmer. "For each person that signs up to participate in the Get Moving
America challenge, AstraZeneca will make a $1 donation to the Arthritis
Foundation, up to $25,000. The funds raised will help the Arthritis Foundation
serve the 50 million adults and 300,000 children affected by the disease."
Led by Olympic gold medalist Dorothy Hamill, who has OA, Get Moving America
can be found on Facebook at www.facebook.com/getmovingamerica and on Twitter,
Pinterest, and YouTube. The campaign features a 90-Day challenge for users to
log on daily and discover new exercise routines from celebrity fitness
trainer, Terri Walsh, obtain tips from Dorothy Hamill, unlock virtual fitness
badges, and receive daily motivational messages. Participants can share their
progress and experiences as well as motivate others on the Facebook page and
other social media platforms.
About the Arthritis Foundation
Striking one in every five adults and 300,000 children, arthritis is the
nation's leading cause of disability. The Arthritis Foundation
(www.arthritis.org) is committed to raising awareness and reducing the
unacceptable impact of this serious and painful disease, which can severely
damage joints and rob people of living life to its fullest. The Foundation
funds life- changing research that has restored mobility in patients for more
than six decades; fights for health care policies that improve the lives of
the millions who live with arthritis; and partners with families to provide
empowering programs and information.
AstraZeneca is a global, innovation-driven biopharmaceutical business that
focuses on the discovery, development and commercialization of prescription
medicines, primarily for the treatment of cardiovascular, metabolic,
respiratory, inflammation, autoimmune, oncology, infection and neuroscience
diseases. AstraZeneca operates in over 100 countries and its innovative
medicines are used by millions of patients worldwide. For more information
please visit: www.astrazeneca.com
Contact: Media Inquiries, Laurie Casaday +1(302)885-2699,
Laurie.Casaday@astrazeneca.com, or Bart Casabona +1(845)797-7660,
Press spacebar to pause and continue. Press esc to stop.